Xtl Biopharmaceuticals (XTLB) Net Income - Minority (2010 - 2015)
Xtl Biopharmaceuticals (XTLB) posted quarterly Net Income - Minority of -$2000.0 for Q4 2015, down 100.59% year-on-year from $338000.0 in Q4 2014, and little changed on a QoQ basis from -$2000.0 in Q3 2015.
Xtl Biopharmaceuticals (XTLB) Net Income - Minority (2010 - 2015) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Net Income - Minority for 6 consecutive years, with -$2000.0 the latest figure, recorded in Q4 2015.
- Quarterly Net Income - Minority fell 100.59% year-over-year to -$2000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was -$2000.0 (down 100.59% YoY) and the FY2015 annual result came in at -$2000.0, down 100.59% from the prior year.
- Net Income - Minority steadied at -$2000.0 in Q4 2015 per XTLB's latest filing, from -$2000.0 in the prior quarter.
- Over the last five years, Net Income - Minority for XTLB reached as high as $1.2 million in Q4 2013 and fell as low as -$2000.0 in Q1 2015.
- A 5-year average of $276000.0 and a median of $230000.0 in 2013 frame the typical range for Net Income - Minority.
- Annual changes were most pronounced in 2013 — Net Income - Minority jumped 475.0% — and 2015, when it sank 102.67%.
- Year by year, Net Income - Minority stood at $361000.0 in 2011, then dropped by 2.49% to $352000.0 in 2012, then surged by 251.42% to $1.2 million in 2013, then tumbled by 72.68% to $338000.0 in 2014, then plunged by 100.59% to -$2000.0 in 2015.
- According to Business Quant data, Net Income - Minority over the past three periods registered -$2000.0, -$2000.0, and -$2000.0 for Q4 2015, Q3 2015, and Q2 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -2,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Jun 30, 2015 | -2,000.00 |
| Mar 31, 2015 | -2,000.00 |
| Dec 31, 2014 | 338,000.00 |
| Sep 30, 2014 | 280,000.00 |
| Jun 30, 2014 | 222,000.00 |
| Mar 31, 2014 | 75,000.00 |
| Dec 31, 2013 | 1.24 Mn |
| Sep 30, 2013 | 575,000.00 |
| Jun 30, 2013 | 471,000.00 |
| Mar 31, 2013 | 230,000.00 |
| Dec 31, 2012 | 352,000.00 |
| Sep 30, 2012 | 100,000.00 |
| Jun 30, 2012 | 185,000.00 |
| Mar 31, 2012 | 103,000.00 |
| Dec 31, 2011 | 361,000.00 |
| Sep 30, 2011 | 428,000.00 |
| Jun 30, 2011 | 295,000.00 |
| Dec 31, 2010 | 905,000.00 |